Estimating the global burden of Epstein–Barr virus-related cancers

Y Wong, MT Meehan, SR Burrows, DL Doolan… - Journal of Cancer …, 2022 - Springer
Background More than 90% of the adult population globally is chronically infected by the
Epstein–Barr virus (EBV). It is well established that EBV is associated with a number of …

Childhood cancer burden: a review of global estimates

N Bhakta, LM Force, C Allemani, R Atun, F Bray… - The lancet …, 2019 - thelancet.com
year net survival of children and adolescents diagnosed with cancer is approximately 80%
in many high-income countries. This estimate is encouraging as it shows the substantial …

Epstein–Barr virus-associated lymphomas

C Shannon-Lowe, AB Rickinson… - … Transactions of the …, 2017 - royalsocietypublishing.org
Epstein–Barr virus (EBV), originally discovered through its association with Burkitt
lymphoma, is now aetiologically linked to a remarkably wide range of lymphoproliferative …

MYC deregulation in primary human cancers

M Kalkat, J De Melo, KA Hickman, C Lourenco… - Genes, 2017 - mdpi.com
MYC regulates a complex biological program by transcriptionally activating and repressing
its numerous target genes. As such, MYC is a master regulator of many processes, including …

The COVID‐19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global

M Sullivan, E Bouffet… - Pediatric blood & …, 2020 - Wiley Online Library
The COVID‐19 pandemic is one of the most serious global challenges to delivering
affordable and equitable treatment to children with cancer we have witnessed in the last few …

Implications of genetic and epigenetic alterations of CDKN2A (p16INK4a) in cancer

R Zhao, BY Choi, MH Lee, AM Bode, Z Dong - EBioMedicine, 2016 - thelancet.com
Aberrant gene silencing is highly associated with altered cell cycle regulation during
carcinogenesis. In particular, silencing of the CDKN2A tumor suppressor gene, which …

Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge

C Rodriguez-Galindo, P Friedrich… - Journal of Clinical …, 2015 - ascopubs.org
Advances in the treatment of childhood cancers have resulted in part from the development
of national and international collaborative initiatives that have defined biologic determinants …

Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma

N Wang, GZ Zeng, JL Yin, ZX Bian - Biochemical and biophysical research …, 2019 - Elsevier
Currently, there is no effective treatment for Burkitt's lymphoma in patients aged above 60
years, and thus research on effective treatment options for Burkitt's lymphoma has been …

Cancer in africa 2012

DM Parkin, F Bray, J Ferlay, A Jemal - Cancer Epidemiology, Biomarkers & …, 2014 - AACR
Background: Noncommunicable diseases, and especially cancers, are recognized as an
increasing problem for low and middle income countries. Effective control programs require …

The treatment of Burkitt lymphoma in adults

J Crombie, A LaCasce - Blood, The Journal of the American …, 2021 - ashpublications.org
Burkitt lymphoma (BL) is a highly aggressive, B-cell, non-Hodgkin lymphoma categorized
into endemic, sporadic, and immunodeficiency-associated subtypes. BL has distinct …